Characterization of the Mechanism of Interaction in Ibuprofen‐Eudragit RL100® Coevaporates

References

• Ford J. L. The current status of solid dispersions. Pharm. Acta Helv. 1986; 61: 69–87
   PubMedGoogle Scholar
• Kislalioglu M. S., Khan M. A., Blount C., Goettsh R. W., Bolton S. Physical characterization and dissolution properties of ibuprofen: Eudragit coprecipitates. J. Pharm. Sci. 1981; 80: 799–804
   Google Scholar
• Beten D. B., Moes A. J. Controlled‐release coevaporates of dipyridamole prepared with acrylic polymers. Int. J. Pharm. 1994; 103: 243–251
   Web of Science ®Google Scholar
• Karnachi A. A., De Hon R. A., Khan M. A. Compression of indomethacin coprecipitates with polymer mixtures: effect of preparation methodology. Drug Dev. Ind. Pharm. 1995; 21: 1473–1483
   Web of Science ®Google Scholar
• Khan M. A., Dib J., Reddy I. K. Statistical optimization of ketoprofen‐Eudragit S100 coprecipitates to obtain controlled‐release tablets. Drug Dev. Ind. Pharm. 1996; 22: 135–141
   Web of Science ®Google Scholar
• Benita S., Hoffman A., Donbrow M. Microencapsulation of paracetamol using polyacrylate resins (Eudragit Retard), kinetics of drug release and evaluation of kinetic model. J. Pharm. Pharmacol. 1985; 37: 391–395
   PubMed Web of Science ®Google Scholar
• Goto S., Kawata M., Nakamura M., Maekauwa K., Ayoama T. Eudragit RS and RL (acrylic resins) microcapsules as pH insensitive and sustained release preparations of ketoprofen. J. Microencapsul 1986; 3: 293–304
   PubMedGoogle Scholar
• Kawata M., Nakamura M., Goto T., Ayoama T. Preparation and dissolution pattern of Eudragit RS microcapsules containing Ketoprofen. Chem. Pharm. Bull. 1986; 34: 2618–2623
   PubMed Web of Science ®Google Scholar
• Kawashima Y., Iwamoto T., Niwa T., Takeuchi H., Hino T. Size control of ibuprofen microspheres with an acrylic polymer by changing the pH in an aqueous dispersion medium and its mechanism. Chem. Pharm. Bull. 1993; 41: 191–195
   Web of Science ®Google Scholar
• Murthy T. E.G.K., Verma P. R.P. Controlled transdermal delivery of flurbiprofen films using mixed grades of Eudragit: design, in‐vitro and in‐vivo evaluation. Int. J. Pharm. Adv. 1996; 1: 391–397
   Google Scholar
• Pignatello R., Vandelli M. A., Giunchedi P., Puglisi G. Properties of tolmetin‐loaded Eudragit® RL100 and RS100 microparticles prepared by different techniques. STP Pharma Sci. 1997; 7: 148–157
   Google Scholar
• Pignatello R., Ferro M., De Guidi G., Salemi G., Vandelli M. A., Guccione S., Geppi M., Forte C., Puglisi G. Preparation, characterisation and photosensitivity studies of solid dispersions of diflunisal and Eudragit RS100 and RL100. Int. J. Pharm. 2001; 218: 27–42
   PubMed Web of Science ®Google Scholar
• Pignatello R., Amico D., Chiechio S., Spadaro C., Puglisi G., Giunchedi P. Preparation and analgesic activity of Eudragit® RS100 microparticles containing diflunisal. Drug Deliv. 2001; 8: 35–45
   PubMed Web of Science ®Google Scholar
• Pignatello R., Spedalieri G., Bucolo C., Maltese A., Puglisi G. Flurbiprofen‐loaded acrylate polymer nanosuspensions for ophthalmic application. Biomaterials 2002; 23: 3247–3255, [CSA]
   PubMed Web of Science ®Google Scholar
• Valle‐Jones J. C., Smith J., Rowley‐Jones D. A comparison in general practice of once and twice daily sustained‐release ibuprofen and standard ibuprofen in the treatment of non‐articular rheumatism. Br. J. Clin. Pract. 1984; 38: 353–358
   PubMedGoogle Scholar
• Kawashima Y., Niwa T., Handa T., Takeuchi H., Iwamoto T., Itoh K. Preparation of controlled‐release microspheres of ibuprofen with acrylic polymers by a novel quasi‐emulsion solvent diffusion method. J. Pharm. Sci. 1989; 78: 68–72
   PubMed Web of Science ®Google Scholar
• Dubernet C., Rouland J. C., Benoit J. P. Ibuprofen‐loaded ethylcellulose microspheres: analysis of the matrix structure by thermal analysis. J. Pharm. Sci. 1991; 80: 1029–1033
   PubMed Web of Science ®Google Scholar
• Kawashima Y., Niwa T., Takeuchi H., Hino T., Ito Y. Control of prolonged drug release and compression properties of ibuprofen microsponges with acrylic polymer, Eudragit RS, by changing their intraparticle porosity. Chem. Pharm. Bull. 1992; 40: 196–201
   PubMed Web of Science ®Google Scholar
• Bodmeier R., Wang J. Microencapsulation of drugs with aqueous colloidal polymer dispersions. J. Pharm. Sci. 1993; 82: 191–194
   PubMed Web of Science ®Google Scholar
• Theis D. L., Lucisano L. J., Halstead G. W. Use of stable isotopes for evaluation of drug delivery systems: comparison of ibuprofen release in vivo and in vivo from two biphasic release formulations utilizing different rate‐controlling polymers. Pharm. Res. 1994; 11: 1069–1076
   PubMed Web of Science ®Google Scholar
• Palmieri G. F., Lovato D., Martelli S. New controlled‐release ibuprofen tablets. Drug Dev. Ind. Pharm. 1999; 25: 671–677, [CSA]
   PubMed Web of Science ®Google Scholar
• Kachrimanis K., Nikolakakis I., Malamataris S. Spherical crystal agglomeration of ibuprofen by the solvent‐change technique in presence of methacrylic polymers. J. Pharm. Sci. 2000; 89: 250–259
   PubMed Web of Science ®Google Scholar
• Perumal D. Microencapsulation of ibuprofen and Eudragit RS 100 by the emulsion solvent diffusion technique. Int. J. Pharm. 2001; 218: 1–11
   PubMed Web of Science ®Google Scholar
• Kidokoro M., Shah N. H., Malick A. W., Infeld M. H., McGinity J. W. Properties of tablets containing granulations of ibuprofen and an acrylic copolymer prepared by thermal processes. Pharm. Dev. Technol. 2001; 6: 263–275, [CSA]
   PubMed Web of Science ®Google Scholar
• Oth M. P., Moes A. J. Sustained release solid dispersions of indomethacin with Eudragit RS and RL. Int. J. Pharm. 1989; 55: 157–164
   Web of Science ®Google Scholar
• Jenquin M. R., Liebowitz S. M., Sarabia R. E., McGinity J. W. Physical and chemical factors influencing the release of drugs from acrylic resin films. J. Pharm. Sci. 1990; 79: 811–816
   PubMed Web of Science ®Google Scholar
• Pignatello R., Ferro M., Puglisi G. Preparation of solid dispersions of non‐steroidal anti‐inflammatory drugs with acrylic polymers and studies on mechanisms of drug‐polymer interactions. AAPS PharmSciTech 2002; 3, art. 10
   Google Scholar